Aclaris Therapeutics Inc (ACRS)

Deferred Revenue

$3.98M

Quarterly · Period ending: · USD

ACRS logo

ACRS Deferred Revenue

Latest reported$3.98M
ACRS Quarterly Deferred Revenue ($0.00 → $3.98M)
High-resolution chart · PNG

ACRS deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aclaris Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
3,976,000
3,972,000
3,943,000
6,297,000
9,330,000
0
3,890,000
3,765,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,066,000
0
19,918,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.